ANAGENICS LIMITED
ASX:AN1Pharmaceuticals, Biotechnology & Life SciencesToday’s holders own 89.0% of what they think they own, once every option and right converts.
Share count grew 114% in 24 months; 1 cash raise in 24 months; options/rights overhang 12% of shares
ANAGENICS LIMITED's ordinary share count grew 113.6% between April 2024 and February 2026, reaching 985M shares. In the past 24 months, the company completed one capital raise, a placement in December 2025 that brought in A$2.2M. Options and rights on issue could convert into 122M new shares, representing 12.4% of the current share count, with the nearest expiry in February 2029. No options are currently in the money. As of the June 2026 quarter, the company reported A$931K in available cash, sufficient for approximately 9.5 quarters based on its recent expenditure rate. No proposed securities issues are pending.
Shares on issue — last 2 years
Cash runway
Issuance timeline
Latest 5 filings (Appendix 2A quoted issues, 3G unquoted, 3H cancellations)
| Date | Form | Security | On issue, per this filing | Source |
|---|---|---|---|---|
| 17 Apr 2026 | 3H · cancellation | AN1 : ORDINARY FULLY PAID | 985.5M | Appendix 3H |
| 12 Feb 2026 | 3G · unquoted | AN1 : ORDINARY FULLY PAID | 985.5M | Appendix 3G |
| 8 Feb 2026 | 2A · quoted issue | AN1 : ORDINARY FULLY PAID | 985.5M | Appendix 2A |
| 29 Jan 2026 | 3H · cancellation | AN1 : ORDINARY FULLY PAID | 570.8M | Appendix 3H |
| 29 Jan 2026 | 3H · cancellation | AN1 : ORDINARY FULLY PAID | 570.8M | Appendix 3H |
Capital raises
1 cash raise in the last 24 months · 1 in the last 12 months
Forward supply
Every dated event on record that could add securities to the register — option expiries to their stated dates and proposed issues over the next 18 months, on one timeline.
Placement capacity
How much stock a company can place without asking holders. Listing Rule 7.1 allows 15% of ordinary securities in any 12 months, and every Appendix 3B states how much of it an issue uses.
Pending proposed issues
Options & convertible securities
At $0.006 today, 0 securities are in the money (0.0% of shares on issue). No more priced supply until 1.5× today’s price, which takes it to 122.3M (12.4% of shares).
- Priced supply in the money at the price on the axis — the curve, and the only thing on it. Ten prices, sampled: between two of them the true figure lies between the two.
| Code | Security | Type | Exercise price | Expiry | On issue | Source |
|---|---|---|---|---|---|---|
| AN1AC | Options | Price-triggered | $0.008 | 12 Feb 2029 | 122.3M | Filing |
“Nil” is a stated nil exercise price: nothing is paid to convert. An em dash means the filing names no exercise price at all. Security is read from the filing’s own class description; an em dash there means the description is not one this table labels. One row is one security class, at the number stated in the most recent quotation application that restated it — linked, and dated, in the last column.
Director dealings
| Date | Director | Type | Shares | Options | Other | Value | Source |
|---|---|---|---|---|---|---|---|
| 26 Feb 2026 | Alexander Beard | Buy on-market | 2.9M | — | — | $20k | 3Y notice |
| 16 May 2025 | Alexander Beard | Buy on-market | 56k | — | — | — | 3Y notice |
| 14 May 2025 | Alexander Beard | Buy on-market | 227k | — | — | — | 3Y notice |
Ownership
Latest announcements
Headlines link to the source PDFs on the ASX announcements platform. Data as of 12 Sept 2026.